Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Faes FarmaLTS:0K9H -0.98%82 Dividend Payout Ratio is 0.70 as of Jun. 2026, which is 1% above its 10-year median of 0.69. GuruFocus rates LTS:0K9H with a GF Score™ of 82/100 and a GF Value™ of €5.50 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 447 Drug Manufacturers companies, Faes Farma ranks worse than 63.76% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Faes Farma's Dividend Payout Ratio for the
months ended in Jun. 2026 was 0.70.
The historical rank and industry rank for Faes Farma's Dividend Payout Ratio or its related term are showing as below:
LTS:0K9H'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.24 Med: 0.69 Max: 0.76
Current: 0.47
During the past 13 years, the highest Dividend Payout Ratio of Faes Farma was 0.76. The lowest was 0.24. And the median was 0.69.
LTS:0K9H's Dividend Payout Ratio is ranked worse than 63.76% of 447
companies
in the Drug Manufacturers industry
Industry Median: 0.37
vs LTS:0K9H: 0.47
During the past 12 months, Faes Farma's average Dividends Per Share Growth Rate was -28.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 37.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Faes Farma was 37.40% per year. The lowest was -24.10% per year. And the median was 3.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Faes Farma (LTS:0K9H) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Faes Farma Dividend Payout Ratio Related Terms
Faes Farma Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Faes Farma's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0K9H vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Faes Farma's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Faes Farma's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma (LTS:0K9H) has a Dividend Payout Ratio of 0.70 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Faes Farma and its competitors. This is near median its historical median of 0.69. Over the past decade, Faes Farma's Dividend Payout Ratio has ranged from 0.24 to 0.76. According to the industry distribution chart, Faes Farma ranks #285 out of 447 companies in the Drug Manufacturers industry, placing it in the top 63.8%.
Is Faes Farma's Dividend Payout Ratio too high?
Faes Farma's current Dividend Payout Ratio of 0.70 is near median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 0.76. The Drug Manufacturers industry median Dividend Payout Ratio is 0.37. Faes Farma's value of 0.70 is 89.2% above this industry median. Based on the distribution chart, Faes Farma ranks #285 out of 447 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Faes Farma has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Faes Farma ranks #285 out of 447 companies for Dividend Payout Ratio. This places Faes Farma in the lower half of its industry. The industry median Dividend Payout Ratio is 0.37. Faes Farma's value of 0.70 is 89.2% above this benchmark. Historically, Faes Farma's own Dividend Payout Ratio has ranged from 0.24 to 0.76 over the past decade. While the company's 10-year median is 0.69 vs. the industry median of 0.37, Faes Farma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.37, based on 447 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Faes Farma's current Dividend Payout Ratio of 0.70 is 89.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Faes Farma and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Faes Farma's current Dividend Payout Ratio is 0.70, which is near median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (LTS:0K9H) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.50, compared to a current price of €4.53 — trading 17.7% below its estimated fair value. The current Dividend Payout Ratio is 0.70, which is near median its 10-year median of 0.69 and 89.2% above the Drug Manufacturers industry median of 0.37. Faes Farma's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Faes Farma (LTS:0K9H), the current Dividend Payout Ratio is 0.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (LTS:0K9H) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.53 is trading 17.7% below its estimated GF Value™ of €5.50.
GuruFocus considers Faes Farma to be Modestly Undervalued.
Key valuation signals for LTS:0K9H:
Dividend Payout Ratio: 0.70 (near median its 10-year median of 0.69)
GF Value™: €5.50 vs. price of €4.53 (17.7% below fair value)
Industry Position: 89.2% above the Drug Manufacturers median (#285 of 447)
No single metric tells the full story. See the LTS:0K9H stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
82GF Score
Get the complete analysis for LTS:0K9H
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0K9H has been successfully added to your 
